Medopharm — Doxycycline Exporter Profile
Indian Pharmaceutical Exporter · #13 for Doxycycline · $1.2M export value · DGFT Verified
Medopharm is the #13 Indian exporter of Doxycycline with $1.2M in export value and 48 verified shipments. Medopharm holds a 1.0% market share in Doxycycline exports across 21 countries. The company exports 21 pharmaceutical products worth $50.2M across 10 therapeutic categories.
Medopharm — Doxycycline Export Profile: Buyers & Destinations
Where Does Medopharm Export Doxycycline?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $200.2K | 12 | 19.9% |
| AFGHANISTAN | $135.2K | 3 | 13.5% |
| SRI LANKA | $118.0K | 4 | 11.7% |
| MALAWI | $100.0K | 2 | 10.0% |
| SUDAN | $88.7K | 2 | 8.8% |
| UNITED ARAB EMIRATES | $50.5K | 5 | 5.0% |
| NIGERIA | $50.0K | 1 | 5.0% |
| MOZAMBIQUE | $45.9K | 4 | 4.6% |
| YEMEN DEMOCRATIC | $44.0K | 1 | 4.4% |
| MADAGASCAR | $43.2K | 1 | 4.3% |
Medopharm exports Doxycycline to 22 countries. The largest destination is NETHERLANDS accounting for 19.9% of Medopharm's Doxycycline shipments, followed by AFGHANISTAN (13.5%) and SRI LANKA (11.7%). These destinations reflect Medopharm's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Doxycycline from Medopharm?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| THE MEDICAL EXPORT GROUP | NETHERLANDS | $129.2K | 6 |
| M/S. MINISTRY OF HEALTH AND INDIGEN | SRI LANKA | $118.0K | 4 |
| UNITED NATIONS CHILDRENS FUND. | AFGHANISTAN | $85.2K | 2 |
| UNICEF | NIGERIA | $50.0K | 1 |
| UNICEF KABUL | AFGHANISTAN | $50.0K | 1 |
| MINISTRY OF HEALTH AND POPULATION | MALAWI | $50.0K | 1 |
| UNICEF SOUTH SUDAN | SUDAN | $50.0K | 1 |
| MINISTRY OF HEALTH. | MALAWI | $50.0K | 1 |
| WELLWORTH LDA | MOZAMBIQUE | $45.9K | 4 |
| UNICEF SANAA | YEMEN DEMOCRATIC | $44.0K | 1 |
Medopharm supplies Doxycycline to 33 buyers globally. The largest buyer is THE MEDICAL EXPORT GROUP (NETHERLANDS), followed by M/S. MINISTRY OF HEALTH AND INDIGEN (SRI LANKA) and UNITED NATIONS CHILDRENS FUND. (AFGHANISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Doxycycline Export Value and How Much Does Medopharm Contribute?
India exported $35.9M worth of Doxycycline through 5,999 shipments from 408 suppliers to 149 countries, serving 1,051 buyers globally. Medopharm contributes $1.2M to this total, accounting for 1.0% of India's Doxycycline exports. Medopharm ships Doxycycline to 22 countries through 33 buyers.
What Is the Average Shipment Value for Medopharm's Doxycycline Exports?
Medopharm's average Doxycycline shipment value is $25.2K per consignment, based on 48 shipments totaling $1.2M. The largest destination is NETHERLANDS (19.9% of Medopharm's Doxycycline exports).
How Does Medopharm Compare to Other Indian Doxycycline Exporters?
Medopharm ranks #13 among 408 Indian Doxycycline exporters with a 1.0% market share. The top 3 exporters are ALEMBIC PHARMACEUTICALS LIMITED ($7.0M), USV PRIVATE LIMITED ($6.3M), STRIDES PHARMA SCIENCE LIMITED ($4.5M). Medopharm processed 48 shipments to 21 destination countries.
What Doxycycline Formulations Does Medopharm Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DOXYCYCLINE TABLETS BP 100MG | $182.3K | 5 |
| DOXYCYCLINE TABLETS BP 100MG (20717 X 10 | $79.6K | 2 |
| DOXYCYCLINE TABLETS BP 100MG (10000 X 10 | $60.1K | 3 |
| DOXYCYCLINE TABLETS BP 100MG(104880 X 10 | $50.0K | 1 |
| DOXYCYCLINE TABLETS BP 100MG (31100 X 10 | $50.0K | 1 |
| DOXYCYCLINE TABLETS BP 100MG 29700 X 10 | $50.0K | 1 |
| DOXYCYCLINE TABLETS BP 100MG (6000 X 100X 10) - BOX | $50.0K | 1 |
| DOXYCYCLINE TABLETS BP 100MG 23540 X 10X 10 BOX | $44.0K | 1 |
| DOXYCYCLINE TABLETS BP 100MG (1000 X 100 | $37.8K | 2 |
| DOXYCYCLINE TABLETS BP 100MG (18310 X 10X 10) - BOX | $35.2K | 1 |
Medopharm exports 39 distinct Doxycycline formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DOXYCYCLINE TABLETS BP 100MG with 5 shipments worth $182.3K.
How Does Medopharm Compare to Nearest Doxycycline Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | GRACURE PHARMACEUTICALS LIMITED | $1.8M | 51 | 1 | $35.8K |
| 12 | S KANT HEALTHCARE LIMITED | $1.2M | 45 | 3 | $27.2K |
| 13 | MEDOPHARM ★ | $1.2M | 48 | 21 | $25.2K |
| 5 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $1.1M | 23 | 1 | $50.0K |
| 9 | GLAND PHARMA LTD | $1.1M | 23 | 1 | $50.0K |
Medopharm ranks #13 among 408 Indian Doxycycline exporters. Average shipment value of $25.2K compared to the market average of $87.9K. The closest competitors by value are GRACURE PHARMACEUTICALS LIMITED and S KANT HEALTHCARE LIMITED.
Which Indian Ports Ship Doxycycline Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,633 | 27.2% |
| SAHAR AIR | 1,215 | 20.3% |
| NHAVA SHEVA SEA (INNSA1) | 338 | 5.6% |
| DELHI AIR CARGO ACC (INDEL4) | 336 | 5.6% |
| Bombay Air | 315 | 5.3% |
| DELHI AIR | 219 | 3.7% |
| JNPT | 188 | 3.1% |
| JNPT/ NHAVA SHEVA SEA | 156 | 2.6% |
What Other Antibiotics Products Does Medopharm Export?
Medopharm also exports these antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Medopharm's Doxycycline Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medopharm. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended transit times. These disruptions have particularly impacted trade corridors through the Persian Gulf and the Strait of Hormuz, vital for India's drug shipments. (pharmaceuticalcommerce.com)
Conversely, US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of 100% tariffs on branded or patented pharmaceutical products by the US in October 2025 poses a significant challenge. While generic drugs may remain largely unaffected, companies like Medopharm must navigate these policy shifts carefully. (itisbl.com)
The recent India–European Union Free Trade Agreement, concluded in January 2026, offers a favorable development. The agreement eliminates tariffs on most European pharmaceutical exports to India and vice versa, potentially enhancing market access for Indian companies in the EU. (en.wikipedia.org)
Medopharm — Regulatory Compliance & Quality Standards
India's pharmaceutical industry has made significant strides in regulatory compliance, with the country surpassing the US in the number of FDA-registered generic manufacturing sites as of 2024. This achievement reflects improved adherence to international quality standards, a critical factor for exporters like Medopharm. (business-standard.com)
However, the industry faces challenges related to quality compliance, as evidenced by incidents involving contaminated products. Maintaining rigorous quality control measures is essential for sustaining global trust and market access. (economictimes.indiatimes.com)
About Medopharm
Medopharm exports 21 products worth $50.2M. Beyond Doxycycline, top products include Amoxicillin, Metronidazole, Paracetamol, Albendazole, Ciprofloxacin. View the complete Medopharm profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Doxycycline — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Doxycycline shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medopharm matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 50 individual customs records matching Medopharm exporting Doxycycline, covering 39 formulations to 22 countries via 33 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 149+ countries, 1,051+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Doxycycline Export Data from Medopharm
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medopharm's Doxycycline exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medopharm
Full Company Profile →
21 products · $50.2M total trade · 10 categories
Doxycycline Stats
Company Overview
Top Products by Medopharm
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medopharm.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Doxycycline. For current shipment-level data, contact TransData Nexus.